dobutamine has been researched along with Shock, Septic in 171 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (13.45) | 18.7374 |
| 1990's | 54 (31.58) | 18.2507 |
| 2000's | 48 (28.07) | 29.6817 |
| 2010's | 38 (22.22) | 24.3611 |
| 2020's | 8 (4.68) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, JK; Ding, SS; Liu, M; Shang, XK; Zhou, WJ | 1 |
| Contrim, L; de Oliveira, N; Fernandes, L; Gandolfi, J; Garcia Soriano, F; Gomes, B; Lobo, S; Pereira, R; Silva, J | 1 |
| Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
| Chen, N; Cui, N; Ding, XX; Li, N; Sun, T; Wang, SH; Yu, ZB; Zhang, N | 1 |
| Petros, S | 1 |
| Fang, X; Huang, P; Jin, H; Liu, F; Ma, Z; Wang, S | 1 |
| Belletti, A; De Domenico, P; Landoni, G; Lembo, R; Morselli, F; Mucchetti, M; Nagy, A; Putzu, A; Sartini, C; Sartorelli, M; Zangrillo, A | 1 |
| Ariyoshi, N; Crossey, E; Devendra, G; Hamahata, N; Hasegawa, D; Ishihara, T; Nasu, M; Sato, R | 1 |
| Arango-Dávila, CA; Bermudez, WF; Bruhn, A; De Backer, D; Echeverri, GJ; García Marin, AF; Hernández, G; Madriñán-Navia, H; Marulanda, A; Ospina-Tascón, GA; Quiñones, E; Rodríguez, F; Valencia, JD | 1 |
| Baidya, DK; Bhattacharjee, S; Maitra, S; Soni, KD | 1 |
| Annane, D; Cavazzoni, SZ; de Backer, D; DU, B; Gordon, AC; Hernández, G; Olsen, KM; Osborn, TM; Ouanes-Besbes, L; Peake, S; Russell, JA | 1 |
| Annane, D; De Backer, D; Lee, T; Russell, JA; Singer, J | 1 |
| Aneman, A; Wernerman, J | 1 |
| Aquevedo, A; Bruhn, A; Castro, R; Florez, J; Fuentealba, A; Hernandez, G; Ince, C; Kattan, E; Luengo, C; McNab, P; Pairumani, R; Regueira, T | 1 |
| Benzidi, Y; Gasan, G; Lemyze, M; Mallat, J; Pepy, F; Salleron, J; Thevenin, D; Tronchon, L; Vallet, B; Vangrunderbeeck, N | 1 |
| Dubey, NK; Sankar, J; Sankar, MJ; Singh, A; Suresh, CP | 1 |
| Kumar, P; Kumar, RM; Saini, SS | 1 |
| Lone, NA; Oba, Y | 1 |
| McNeilly, RG | 1 |
| Bailey, M; Bellomo, R; Cameron, PA; Cooper, DJ; Delaney, A; Higgins, AM; Holdgate, A; Howe, BD; Peake, SL; Webb, SA; Williams, P | 1 |
| Waltzman, ML | 1 |
| Du, ZH; Hu, B; Li, JG; Lu, ZH; Ma, PL; Pei, XB; Yun, L; Zhou, Q | 1 |
| Bignami, E; De Luca, M; Di Tomasso, N; Frau, G; Landoni, G; Likhvantsev, V; Lomivorotov, V; Monaco, F; Oriani, A; Putzu, A; Zangrillo, A | 1 |
| AbuAlreesh, S; Hussain, T; Kent, P; Nadeem, R; Singh, M; Sockanathan, S | 1 |
| Dai, J; Du, M; Guo, C; Rao, Z; Sun, G; Tang, R; Wang, W; Wang, Y; Xu, F; Zhou, M | 1 |
| Asmussen Andreasen, R; Emamifar, A; Jensen Hansen, IM; Skaarup Andersen, N | 1 |
| Hu, MH; Ji, CL; Lai, ZZ; Meng, JB; Tian, S; Xu, XJ; Zhang, G | 1 |
| Lu, S; Nguyen, HB; Possagnoli, I; Stokes, P | 1 |
| Angelini, GD; Belletti, A; Benedetto, U; Biondi-Zoccai, G; Landoni, G; Leggieri, C; Silvani, P; Zangrillo, A | 1 |
| Arbo, JE; Berlin, DA; Stratton, L | 1 |
| Kalish, BT | 1 |
| Ferjani, M; Hajjej, Z; Labbene, I; Meddeb, B; Morelli, A; Sellami, W | 1 |
| Beale, R | 1 |
| Coleman, N; Miller, A | 1 |
| Bulsara, M; Chamberlain, J; Harding, R; Ho, KM | 1 |
| Carvalho, WB; Castelo, JS; Elias-Neto, J; Oliveira, NS; Pereira, FE; Silva, VR | 1 |
| Barbeiro, DF; De Backer, D; Dimopoulos, G; Lobo, SM; Preiser, JC; Soriano, FG; Sun, Q; Tu, Z; Vercruysse, V; Vincent, JL; Vray, B | 1 |
| Baredes, N; Bruhn, A; Dubin, A; Hernández, G; Knobel, E; Lazzeri, S; Palizas, F; Regueira, T | 1 |
| Bachetoni, A; Cecchini, V; D'Alessandro, M; Ertmer, C; Lange, M; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Van Aken, H; Westphal, M | 1 |
| Abdullah, GM; Alhashemi, JA; Alotaibi, QA; Shalabi, SA | 1 |
| Blomquist, S; Cunha-Goncalves, D; Larsson, A; Perez-de-Sa, V; Thörne, J | 1 |
| Geilfus, D; Graf, BM; Missler, G; Sinner, B; Zausig, YA; Zink, W | 1 |
| Guia, IL; Lessa, MA; Nacul, FE; Tibiriçá, E | 1 |
| Arnold, RC; Claremont, HA; Jones, AE; Kline, JA; Shapiro, NI; Trzeciak, S | 1 |
| Delaney, RR; Holt, DB; Uyehara, CF | 1 |
| Chapman, MJ; Edwards, J; Ho, JT; Lam, S; Lewis, JG; Ludbrook, G; O'Connor, S; Torpy, DJ | 1 |
| Carneiro, AH; Póvoa, P | 1 |
| Groeneveld, AB; Hartemink, KJ | 1 |
| Jozwiak, M; Monnet, X; Persichini, R; Teboul, JL | 1 |
| Inal, MT; Memiş, D; Sut, N | 1 |
| Azevedo, LC; Brunialti, MK; Fernandes, D; Laurindo, FR; Mendes, M; Park, M; Rapozo, M; Rosário, AL; Salomão, R; Schettino, GP | 1 |
| Botte, A; Cremer, R; Lampin, ME; Leclerc, F; Rousseaux, J; Sadik, A | 1 |
| Akamatsu, S; Hashimoto, T; Hayashi, K; Kojima, A; Tanaka, A | 1 |
| Dubin, A; Enrico, C; Ince, C; Kanoore Edul, VS; Pein, MC; Pérez de la Hoz, RA; Vazquez, AR | 1 |
| Parviainen, I; Ruokonen, E; Uusaro, A | 1 |
| De Backer, D; Dimopoulos, G; Lobo, S; Nagy, N; Rogiers, P; Sun, Q; Tu, Z; Vincent, JL | 1 |
| Bénard, P; Daccache, G; Fellahi, JL; Gérard, JL; Mourgeon, E | 1 |
| Li, SQ; Qiu, HB; Tan, Y; Yang, Y; Zhou, SX | 2 |
| Alaya, S; Bahloul, M; Michard, F; Richard, C; Teboul, JL; Zarka, V | 1 |
| Hiltebrand, LB; Krejci, V; Sigurdsson, GH | 1 |
| Martikainen, TJ; Ruokonen, E; Tenhunen, JJ; Uusaro, A | 1 |
| Coluzzi, F; Conti, G; De Gaetano, A; Morelli, A; Orecchioni, A; Pelaia, P; Pietropaoli, P; Rocco, M; Vernaglione, E | 1 |
| Bennett, ED; Rhodes, A | 1 |
| Beale, RJ; Hollenberg, SM; Parrillo, JE; Vincent, JL | 1 |
| Creteur, J; De Backer, D; Dubois, MJ; Koch, M; Sakr, Y; Verdant, C; Vincent, JL | 1 |
| Abate, NL; Cowan, RM; Dellinger, RP; Kilgannon, JH; Parrillo, JE; Stauss, M; Trzeciak, S; Zanotti, S | 1 |
| Creteur, J; De Backer, D; Koch, M; Sakr, Y; Vincent, JL | 1 |
| Groeneveld, AB; Jellema, WT; Thijs, LG; van Lieshout, JJ; Wesseling, KH; Westerhof, N | 1 |
| Dünser, M; Friesenecker, B; Hasibeder, W; Knotzer, H | 1 |
| Schultz, MJ; Spronk, PE | 1 |
| Dries, DJ | 1 |
| Barán, M; Canales, HS; Dubin, A; Edul, VS; Estenssoro, E; Etcheverry, G; Maskin, B; Murias, G; Pozo, MO; Sottile, JP | 1 |
| Koch, T; Ragaller, M; Theilen, H | 1 |
| Singer, M | 1 |
| Annane, D; Azoulay, E; Bellissant, E; Bollaert, PE; Charpentier, C; Martin, C; Nitenberg, G; Papazian, L; Renault, A; Ricard, JD; Troché, G; Vignon, P | 1 |
| Bruhn, A; Su, F; Vincent, JL; Wang, Z; Yang, X | 1 |
| Abazine, A; Krim, G; Rakza, T; Storme, L; Tourneux, P | 1 |
| Ragaller, M | 1 |
| Cariou, A; Charpentier, J; Chiche, JD; Dhainaut, JF; Laurent, I; Monchi, M; Pinsky, MR; Vinsonneau, C | 1 |
| Dünser, M; Ertmer, C; Lange, M; Morelli, A; Pietropaoli, P; Rehberg, S; Van Aken, H; Westphal, M | 1 |
| Ali, A; Bunnell, E; Kumar, A; Milcarek, B; Parrillo, JE; Schupp, E | 1 |
| Collin, S; Levy, B; Sennoun, N | 1 |
| Benchekroune, S; Berton, C; Chaara, M; Karpati, PC; Laisné, MJ; Mateo, J; Mebazaa, A; Nathan, C; Payen, D; Riché, F | 1 |
| Brunet, F; Carli, A; Dhainaut, JF; Huyghebaert, MF; Monsallier, JF; Schlemmer, B; Villemant, D | 1 |
| Borel, CO; Chodoff, P; Majerus, TC | 1 |
| Dabasaki, T; Funato, H; Ohnishi, H; Sato, M; Uemura, A; Yamaguchi, K | 1 |
| Brandt, D; Klein, W; Pristautz, H | 1 |
| Houston, MC | 1 |
| McCaig, D; Parratt, JR | 1 |
| Bachet, J; Bricard, C; Carli, A; Dallot, JY; Dhainaut, JF; Huet, Y; Kahan, A; Monsallier, FJ; Neveux, E | 1 |
| Bazin, M; Bourokba, A; Jardin, F; Margairaz, A; Sportiche, M | 1 |
| Depeursinge, F; Perret, C | 1 |
| Bredle, DL; Grenzer, O; Hannemann, L; Meier-Hellmann, A; Reinhart, K | 1 |
| Ruokonen, E; Takala, J; Uusaro, A | 2 |
| Dasta, JF; Flancbaum, LJ; Klem, C; Reilley, TE | 1 |
| Hannemann, L; Korell, R; Meier-Hellmann, A; Reinhart, K | 1 |
| Dodam, JR; Gengo, PJ; Hellyer, PW; Jones, JL | 1 |
| Chagnon, JL; Chopin, C; Fourrier, F; Jallot, A; Jourdain, M; Leclerc, L; Racadot, A; Rime, A | 1 |
| Martin, C; Papazian, L; Perrin, G | 1 |
| Hannemann, L; Meier-Hellmann, A; Reinhart, K; Schaffartzik, W; Specht, M; Spies, C | 1 |
| Preiser, JC; Vincent, JL | 1 |
| Chelly, FD; Cromeens, DM; Griffith, OW; Kilbourn, RG | 1 |
| Mulder, MF; Teerlink, T; Thijs, LG; van den Bos, GC; van Kraats, AA; van Lambalgen, AA | 1 |
| DiBona, GF | 1 |
| Hall, JB; Manthous, CA; Pohlman, A; Samsel, RW; Schmidt, GA; Schumacker, PT; Wood, LD | 1 |
| Lee, NH; Orens, JB; Penaranda, R; Silverman, HJ | 1 |
| Bakker, J; Vincent, JL | 1 |
| Hannemann, L; Meier-Hellmann, A; Reinhart, K; Specht, M; Spies, C | 1 |
| Levy, MM; Miyasaki, A; Myers, SA; Smith, P; Takiguchi, SA; Yu, M | 1 |
| Bernard, F; Bertin-Maghit, M; Gueugniaud, PY; Muchada, R; Petit, P | 1 |
| De Backer, D; Manikis, P; Vincent, JL; Zhang, H | 1 |
| Audibert, G; Bauer, P; Bollaert, PE; Charpentier, C; Larcan, A; Levy, B; Nabet, P; Nace, L | 1 |
| Fischer, G; Geisser, W; Georgieff, M; Radermacher, P; Reinelt, H; Vogt, J; Wachter, U; Wiedeck, H | 1 |
| Houltz, E; Lundin, S; Pålsson, J; Ricksten, SE | 1 |
| Bredle, DL; Hannemann, L; Meier-Hellmann, A; Reinhart, K; Specht, M; Spies, CD | 1 |
| Hayes, MA; Hinds, CJ; Palazzo, M; Timmins, AC; Watson, D; Yau, EH | 1 |
| Chagnon, JL; Dupuis, B; Lebleu, N; Marechal, X; Mathieu, D; Nevière, R; Vallet, B; Wattel, F | 1 |
| Bollaert, PE; Larcan, A; Levy, B; Lucchelli, JP; Nace, L; Sadoune, LO | 1 |
| Meier-Hellmann, A; Reinhart, K | 1 |
| Carcillo, JA; Ceneviva, G; Maffei, F; Paschall, JA | 1 |
| Takala, J; Uusaro, A | 1 |
| Hayes, JK; Luo, X; McJames, S; Tseng, CK; Wong, KC | 1 |
| Haglund, U; Ljungdahl, M; Rasmussen, I | 1 |
| Anguel, N; Duranteau, J; Richard, C; Samii, K; Sitbon, P; Teboul, JL; Vicaut, E | 1 |
| Creteur, J; De Backer, D; Vincent, JL | 1 |
| Bollaert, PE; Dousset, B; Larcan, A; Levy, B; Mallie, JP; Nace, L | 1 |
| Arnaud, S; Martin, C; Rougnon, T; Vialet, R; Viviand, X | 1 |
| Bruhn, A; Bugedo, G; Castillo, L; Dagnino, J; Gigoux, J; Hernández, G; Tomicic, V | 1 |
| Bennett, ED; Grounds, RM; Lamb, FJ; Malagon, I; Newman, PJ; Rhodes, A | 1 |
| Bergmann, M; Függer, R; Gornikiewicz, A; Mittlböck, M; Roth, E; Sautner, T; Waldmann, E; Weber, T | 1 |
| Bellenfant, F; Brunet, F; Cariou, A; Chiche, JD; Dhainaut, JF; Joly, LM; Monchi, M | 1 |
| González, F | 1 |
| Meier-Hellmann, A; Reinhart, K; Sakka, SG | 1 |
| Borgers, M; Cherkhaoui, S; De Backer, D; Vincent, JL; Zhang, H | 1 |
| Sanft, C; Schaefer, JH; Schaffartzik, W; Spies, C | 1 |
| Acuña, D; Bruhn, A; Bugedo, G; Castillo, L; Cornu, M; Hernández, G; Inzunza, C; Medeiros, S | 1 |
| Alcázar, R; Ortega-Carnicer, J; Porras, L; Sánchez de la Nieta, D | 1 |
| Kaulfuss, M; Kern, H; Kox, WJ; Martin, M; Schröder, T; Spies, CD | 1 |
| Ronco, JJ | 1 |
| Liu, SH; Qiu, HB; Yang, Y; Zheng, RQ; Zhou, SX | 1 |
| Bellissant, E; Laviolle, B; Le Tulzo, Y; Lessard, Y; Mallédant, Y; Seguin, P; Thomas, R | 1 |
| Huang, YZ; Qiu, HB; Yang, Y; Zheng, RQ; Zhou, SX | 1 |
| Carlet, J; Rapin, M; Régnier, B; Safran, D; Simoneau, G | 1 |
| Benzer, H | 1 |
| Carlet, J; Regnier, B; Safran, D; Teisseire, B | 1 |
| Chopin, C; Mehdaoui, H; Vallet, B | 1 |
| Moulart, D; Preiser, JC; Vincent, JL | 1 |
| Groeneveld, AB; Schneider, AJ; Teule, GJ; Thijs, LG; Wesdorp, RI | 1 |
| Demling, R; LaLonde, C; Youn, YK | 1 |
| Goto, M; Griffin, A | 1 |
| Ibáñez, J; Raurich, JM; Velasco, J | 1 |
| Christ, F; Gamble, J; Gartside, IB; Kox, WJ | 1 |
| al-Saady, N; Bennett, ED; Foshola, TO; Haywood, GA; McKenna, WJ; Moss, R; Pearson, I; Riley, SP; Tighe, D; Webb, A | 1 |
| Blanloeil, Y; Desjars, P; François, T; Lejus, C; Michel, P; Pinaud, M | 1 |
| de Rood, M; Engelman, E; Gilbart, E; Van der Linden, P; Vincent, JL | 1 |
| Aknin, P; Eon, B; Gouin, F; Martin, C; Saux, P | 2 |
| Kahn, RJ; Roman, A; Vincent, JL | 1 |
| Aknin, P; Albanese, J; Eon, B; Gouin, F; Martin, C; Saux, P | 1 |
| Brown, GC; Edwards, JD; Faragher, EB; Nightingale, P; Slater, RM | 1 |
| Goto, M; Griffin, AJ | 1 |
| Groeneveld, AB; Heidendal, GA; Nauta, J; Schneider, AJ; Teule, GJ; Thijs, LG | 1 |
| Edwards, JD; Meadows, D; Nightingale, P; Wilkins, RG | 1 |
| Farr, RW; Lapp, NL; Thomas, DL | 1 |
| Flancbaum, L; Majerus, TC; Tell, B | 1 |
| Azimi, G; Bernard, A; Blecic, S; Domb, M; Van der Linden, P; Vincent, JL | 1 |
| Dhainaut, JF; Huyghebaert, MF | 1 |
| Albertson, TE; Fisher, CJ; Horowitz, Z | 1 |
| Depeursinge, F; Horisberger, JD; Perret, C; Portmann, L | 1 |
23 review(s) available for dobutamine and Shock, Septic
| Article | Year |
|---|---|
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
A Meta-Analysis of the Effects of Levosimendan on Cardiac Function and Outcomes in Patients with Sepsis.
Topics: Dobutamine; Humans; Hydrazones; Pyridazines; Sepsis; Shock, Septic; Simendan; Stroke Volume; Ventricular Function, Left | 2023 |
Effect of Continuous Epinephrine Infusion on Survival in Critically Ill Patients: A Meta-Analysis of Randomized Trials.
Topics: Cardiovascular Diseases; Critical Illness; Dobutamine; Drug Therapy, Combination; Epinephrine; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Norepinephrine; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Shock, Septic; Vasoconstrictor Agents | 2020 |
Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
Topics: Adult; Cardiotonic Agents; Dobutamine; Humans; Hydrazones; Intensive Care Units; Norepinephrine; Pyridazines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan | 2017 |
A global perspective on vasoactive agents in shock.
Topics: Cardiotonic Agents; Dobutamine; Humans; Intensive Care Units; Norepinephrine; Shock; Shock, Septic; Vasoconstrictor Agents | 2018 |
Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
Topics: Arginine Vasopressin; Bayes Theorem; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Norepinephrine; Randomized Controlled Trials as Topic; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2014 |
Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
Topics: Cardiotonic Agents; Dobutamine; Female; Humans; Hydrazones; Male; Middle Aged; Norepinephrine; Pyridazines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan | 2015 |
Impact of Dobutamine in Patients With Septic Shock: A Meta-Regression Analysis.
Topics: Adrenergic beta-1 Receptor Agonists; Adult; Age Factors; Confounding Factors, Epidemiologic; Dobutamine; Humans; Oxygen; Regression Analysis; Shock, Septic; Vascular Resistance | 2017 |
The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
Topics: Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Hydrazones; Network Meta-Analysis; Norepinephrine; Odds Ratio; Pyridazines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2017 |
Vasopressors and Inotropes in Sepsis.
Topics: Cardiotonic Agents; Dobutamine; Emergency Service, Hospital; Heart; Humans; Norepinephrine; Sepsis; Shock, Septic; Vasoconstrictor Agents | 2017 |
Adrenergic support in septic shock: a critical review.
Topics: Adrenergic Agents; Algorithms; Blood Flow Velocity; Blood Pressure; Cardiotonic Agents; Decision Trees; Dobutamine; Dopamine; Epinephrine; Fluid Therapy; Humans; Lypressin; Monitoring, Physiologic; Norepinephrine; Patient Selection; Practice Guidelines as Topic; Resuscitation; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2010 |
Management of myocardial dysfunction in severe sepsis.
Topics: Animals; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Echocardiography; Humans; Sepsis; Severity of Illness Index; Shock, Septic; Thermodilution | 2011 |
Treatment of impaired perfusion in septic shock.
Topics: Adrenal Cortex Hormones; Dobutamine; Fibrinolytic Agents; Fluid Therapy; Humans; Myocardial Contraction; Myocardium; Norepinephrine; Perfusion; Resuscitation; Shock, Septic; Vasopressins | 2002 |
Early goal-directed therapy: an evidence-based review.
Topics: Blood Pressure; Central Venous Pressure; Consensus Development Conferences as Topic; Dobutamine; Erythrocyte Transfusion; Humans; Oxygen; Resuscitation; Sepsis; Shock, Septic; Urine | 2004 |
Vasopressor and inotropic support in septic shock: an evidence-based review.
Topics: Cardiotonic Agents; Catheterization; Consensus Development Conferences as Topic; Dobutamine; Dopamine; Evidence-Based Medicine; Humans; Norepinephrine; Practice Guidelines as Topic; Shock, Septic; Vasoconstrictor Agents | 2004 |
[Microcirculation in sepsis and septic shock - therapeutic options?].
Topics: Ascorbic Acid; Dobutamine; Germany; Humans; Microcirculation; Practice Guidelines as Topic; Practice Patterns, Physicians'; Sepsis; Shock, Septic; Vasculitis; Vasodilator Agents | 2008 |
Oxygen consumption during septic shock. Effects of inotropic drugs.
Topics: Blood Pressure; Cardiotonic Agents; Coronary Circulation; Dobutamine; Hemodynamics; Humans; Lactates; Lactic Acid; Myocardium; Oxygen Consumption; Shock, Septic | 1984 |
Diagnosis and treatment of shock.
Topics: Dobutamine; Dopamine; Humans; Shock; Shock, Cardiogenic; Shock, Septic | 1980 |
[Dopexamine: a new dopaminergic agonist].
Topics: Adrenergic Agonists; Animals; Dobutamine; Dogs; Dopamine; Glomerular Filtration Rate; Heart; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Natriuresis; Rats; Receptors, Dopamine; Shock, Septic; Splanchnic Circulation | 1993 |
Inotropic agents.
Topics: Animals; Cardiotonic Agents; Dobutamine; Humans; Phosphodiesterase Inhibitors; Shock, Septic | 1993 |
Hemodynamic support: volume management and pharmacological cardiovascular support.
Topics: Acute Kidney Injury; Aged; Critical Care; Dobutamine; Dopamine; Fluid Therapy; Humans; Male; Shock, Septic | 1994 |
Catecholamines and splanchnic perfusion.
Topics: Animals; Catecholamines; Contraindications; Dobutamine; Dopamine; Epinephrine; Humans; Norepinephrine; Practice Guidelines as Topic; Shock, Septic; Splanchnic Circulation; Vasodilator Agents | 2000 |
Use of antioxidant therapy in shock and trauma.
Topics: Antioxidants; Dobutamine; Pentoxifylline; Pregnatrienes; Shock, Septic; Shock, Traumatic | 1991 |
37 trial(s) available for dobutamine and Shock, Septic
| Article | Year |
|---|---|
Comparison of norepinephrine, dopamine and dobutamine combined with enteral nutrition in the treatment of elderly patients harboring sepsis.
Topics: Aged; Arterial Pressure; Cardiac Output; Central Venous Pressure; Dobutamine; Dopamine; Enteral Nutrition; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Sepsis; Shock, Septic; Sympathomimetics; Treatment Outcome; Vascular Resistance; Vascular Stiffness | 2021 |
Efficacy of Levosimendan in the Treatment of Patients With Severe Septic Cardiomyopathy.
Topics: Cardiomyopathies; Cardiotonic Agents; Dobutamine; Humans; Hydrazones; Norepinephrine; Prospective Studies; Pyridazines; Sepsis; Shock, Septic; Simendan; Single-Blind Method; Stroke Volume; Ventricular Function, Left | 2023 |
Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study.
Topics: Aged; Cross-Over Studies; Dobutamine; Double-Blind Method; Hemodynamics; Humans; Microcirculation; Middle Aged; Prospective Studies; Resuscitation; Shock, Septic | 2013 |
Goal-directed resuscitation for patients with early septic shock.
Topics: Adult; Aged; Combined Modality Therapy; Critical Illness; Dobutamine; Emergency Service, Hospital; Erythrocyte Transfusion; Female; Fluid Therapy; Humans; Length of Stay; Male; Middle Aged; Renal Replacement Therapy; Respiration, Artificial; Shock, Septic; Survival Analysis; Vasoconstrictor Agents | 2014 |
Effect of dobutamine on extravascular lung water index, ventilator function, and perfusion parameters in acute respiratory distress syndrome associated with septic shock.
Topics: Adult; Aged; Dobutamine; Extravascular Lung Water; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Edema; Respiration, Artificial; Respiratory Distress Syndrome; Shock, Septic | 2016 |
Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
Topics: Biomarkers; Demography; Dobutamine; Fatty Acid-Binding Proteins; Female; Hemodynamics; Humans; Hydrazones; Lactic Acid; Male; Middle Aged; Multivariate Analysis; Myocardium; Natriuretic Peptide, Brain; Pyridazines; Regression Analysis; Shock, Septic; Simendan; Troponin I; Ventricular Function, Left | 2016 |
Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock: A Randomized Controlled Pilot Study.
Topics: Adult; Aged; Dobutamine; Double-Blind Method; Humans; Hydrazones; Male; Middle Aged; Pilot Projects; Pyridazines; Shock, Septic; Simendan | 2017 |
Gastric tonometry versus cardiac index as resuscitation goals in septic shock: a multicenter, randomized, controlled trial.
Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiac Output; Dobutamine; Female; Gastric Mucosa; Hemodynamics; Humans; Hydrogen-Ion Concentration; Intensive Care Units; Ischemia; Length of Stay; Male; Manometry; Middle Aged; Monitoring, Physiologic; Resuscitation; Sensitivity and Specificity; Shock, Septic; Splanchnic Circulation; Survival Analysis; Treatment Outcome | 2009 |
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Topics: Acid-Base Equilibrium; Aged; Dobutamine; Female; Hemodynamics; Homeostasis; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Pilot Projects; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2009 |
Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial.
Topics: Adult; Aged; Cardiotonic Agents; Central Venous Pressure; Dobutamine; Erythrocyte Transfusion; Female; Fluid Therapy; Hospital Mortality; Humans; Lactic Acid; Male; Middle Aged; Oxygen; Prospective Studies; Sepsis; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2010 |
The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock.
Topics: Cardiotonic Agents; Coloring Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hydrazones; Indocyanine Green; Liver Circulation; Liver Function Tests; Male; Metabolic Clearance Rate; Microcirculation; Middle Aged; Prospective Studies; Pyridazines; Regional Blood Flow; Shock, Septic; Simendan | 2012 |
Systemic and microcirculatory effects of dobutamine in patients with septic shock.
Topics: Acid-Base Equilibrium; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Lactic Acid; Male; Microcirculation; Middle Aged; Mouth Floor; Shock, Septic | 2012 |
Effects of short-term fenoldopam infusion on gastric mucosal blood flow in septic shock.
Topics: Adrenergic beta-Agonists; Critical Care; Dobutamine; Double-Blind Method; Female; Fenoldopam; Gastric Acidity Determination; Gastric Mucosa; Hemodynamics; Humans; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Regional Blood Flow; Shock, Septic; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects.
Topics: Acetylcholine; Administration, Topical; Adrenergic beta-Agonists; Aged; Dobutamine; Female; Hemodynamics; Humans; Male; Microcirculation; Middle Aged; Mouth Floor; Shock, Septic; Vasodilator Agents | 2006 |
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
Topics: Adrenergic Agonists; Aged; Dobutamine; Double-Blind Method; Drug Therapy, Combination; Epinephrine; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Norepinephrine; Proportional Hazards Models; Prospective Studies; Shock, Septic; Vasoconstrictor Agents | 2007 |
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Topics: Acid-Base Equilibrium; Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Critical Care; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Oxygen Consumption; Partial Pressure; Pilot Projects; Prospective Studies; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Topics: Aged; APACHE; Blood Pressure; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Intensive Care Units; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Prognosis; ROC Curve; Shock, Septic; Survival Analysis; Vasoconstrictor Agents | 2008 |
Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Prospective Studies; Shock, Septic | 1995 |
[Hypertonic solutions in the intensive care unit].
Topics: Critical Care; Dobutamine; Dose-Response Relationship, Drug; Humans; Hydroxyethyl Starch Derivatives; Hypertonic Solutions; Oxygen; Postoperative Complications; Saline Solution, Hypertonic; Shock, Septic; Ventilators, Mechanical | 1993 |
Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study.
Topics: Adult; Aged; Blood Transfusion; Crystalloid Solutions; Dobutamine; Dopamine; Fees and Charges; Female; Hemodynamics; Hospital Mortality; Humans; Isotonic Solutions; Length of Stay; Male; Middle Aged; Outcome Assessment, Health Care; Oxygen Consumption; Plasma Substitutes; Prospective Studies; Rehydration Solutions; Respiratory Distress Syndrome; Sepsis; Severity of Illness Index; Shock; Shock, Septic | 1993 |
Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Blood Gas Analysis; Dobutamine; Epinephrine; Female; Gastric Mucosa; Hemodynamics; Humans; Hydrogen-Ion Concentration; Lactates; Male; Manometry; Middle Aged; Norepinephrine; Oxygen Consumption; Prospective Studies; Pyruvic Acid; Shock, Septic; Splanchnic Circulation | 1997 |
Epinephrine impairs splanchnic perfusion in septic shock.
Topics: Adult; Aged; Cross-Over Studies; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Prospective Studies; Shock, Septic; Splanchnic Circulation; Sympathomimetics; Vasoconstrictor Agents | 1997 |
Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome.
Topics: Adrenergic alpha-Agonists; Biological Transport; Cardiotonic Agents; Dobutamine; Hemodynamics; Humans; Norepinephrine; Oxygen; Retrospective Studies; Shock, Septic; Systemic Inflammatory Response Syndrome; Treatment Outcome | 1997 |
Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock.
Topics: Analysis of Variance; Carbon Dioxide; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Gastric Mucosa; Hemodynamics; Humans; Hydrogen-Ion Concentration; Lactates; Male; Middle Aged; Partial Pressure; Prospective Studies; Shock, Septic; Time Factors; Vasoconstrictor Agents | 1997 |
Hemodynamic support in fluid-refractory pediatric septic shock.
Topics: Adolescent; Analysis of Variance; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Dopamine; Epinephrine; Fluid Therapy; Hemodynamics; Humans; Infant; Nitroprusside; Norepinephrine; Shock, Septic; Survival Rate; Treatment Outcome; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Cross-Over Studies; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Norepinephrine; Oxygen Consumption; Prospective Studies; Shock, Septic; Survival Analysis; Vasoconstrictor Agents | 1999 |
Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.
Topics: Analysis of Variance; Carbon Dioxide; Dobutamine; Dopamine; Female; Gastric Mucosa; Hemodynamics; Humans; Kidney; Male; Middle Aged; Norepinephrine; Partial Pressure; Prospective Studies; Shock, Septic; Sympathomimetics; Vasodilator Agents | 1999 |
Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Dobutamine; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Prospective Studies; Pulmonary Wedge Pressure; Shock, Septic; Vascular Resistance; Ventricular Function, Left | 1999 |
[Acute effect of dobutamine and amrinone on hemodynamics and splanchnic perfusion in septic shock patients].
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Amrinone; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Shock, Septic; Splanchnic Circulation; Vasodilator Agents | 1999 |
A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock.
Topics: Adult; Aged; Aged, 80 and over; Body Temperature; Cardiotonic Agents; Dobutamine; Exercise Test; Female; Hemodynamics; Hospital Mortality; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Oxygen Consumption; Predictive Value of Tests; Prospective Studies; Sepsis; Severity of Illness Index; Shock, Septic | 1999 |
Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock.
Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Cardiac Output; Dobutamine; Female; Gastric Mucosa; Hemodynamics; Humans; Indocyanine Green; Liver; Male; Middle Aged; Prospective Studies; Regional Blood Flow; Shock, Septic | 1999 |
Different dosages of dobutamine in septic shock patients: determining oxygen consumption with a metabolic monitor integrated in a ventilator.
Topics: Adult; Aged; Bias; Blood Gas Analysis; Calorimetry, Indirect; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Monitoring; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Oxygen Consumption; Prospective Studies; Respiration, Artificial; Shock, Septic | 2000 |
Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients.
Topics: Aged; APACHE; Cardiotonic Agents; Dobutamine; Double-Blind Method; Enoximone; Hemodynamics; Humans; Lidocaine; Liver Circulation; Microsomes, Liver; Middle Aged; Oxygen Consumption; Shock, Septic; Splanchnic Circulation; Tumor Necrosis Factor-alpha | 2001 |
Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aged; Analysis of Variance; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Gastric Mucosa; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Shock, Septic | 2002 |
Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Gastric Mucosa; Hemodynamics; Humans; Middle Aged; Norepinephrine; Oxygen Consumption; Shock, Septic | 2002 |
[Comparative study of the effects of dobutamine and dopamine in septic shock].
Topics: Blood Pressure; Capillaries; Cardiac Output; Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Humans; Myocardial Contraction; Pulmonary Artery; Pulmonary Circulation; Shock, Septic; Stimulation, Chemical; Vascular Resistance | 1978 |
[Relation between oxygen delivery and consumption during septic states. Value of an early dobutamine test].
Topics: Bacterial Infections; Biological Transport; Dobutamine; Humans; Oxygen; Oxygen Consumption; Predictive Value of Tests; Prognosis; Shock, Septic | 1992 |
111 other study(ies) available for dobutamine and Shock, Septic
| Article | Year |
|---|---|
The effects of vasopressors with and without dobutamine on haemodynamics, metabolism and gut injury during endotoxic shock in rabbits. A controlled study.
Topics: Animals; Citrulline; Dobutamine; Hemodynamics; Humans; Lipopolysaccharides; Norepinephrine; Rabbits; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2022 |
[Fluid and vasopressor therapy in sepsis].
Topics: Dobutamine; Hemodynamics; Humans; Norepinephrine; Sepsis; Shock, Septic | 2023 |
Effects of Inotropes on the Mortality in Patients With Septic Shock.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Hospital Mortality; Humans; Milrinone; Retrospective Studies; Shock, Septic | 2021 |
Effects of dobutamine on intestinal microvascular blood flow heterogeneity and O
Topics: Animals; Blood Gas Analysis; Cardiac Output; Dobutamine; Female; Hemodynamics; Intestinal Mucosa; Intestines; Microcirculation; Oxygen; Oxygen Consumption; Regional Blood Flow; Resuscitation; Shock, Septic; Swine | 2017 |
Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Topics: Clinical Trials as Topic; Dobutamine; Dopamine; Epinephrine; Humans; Neurophysins; Norepinephrine; Protein Precursors; Randomized Controlled Trials as Topic; Shock; Shock, Septic; Time Factors; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2018 |
Inotropic support in septic shock?
Topics: Cardiotonic Agents; Dobutamine; Humans; Shock, Septic | 2013 |
Time course of central venous-to-arterial carbon dioxide tension difference in septic shock patients receiving incremental doses of dobutamine.
Topics: Aged; Aged, 80 and over; Blood Gas Analysis; Carbon Dioxide; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Shock, Septic; Time Factors; Ventricular Function, Left | 2014 |
Early goal-directed therapy in pediatric septic shock: comparison of outcomes "with" and "without" intermittent superior venacaval oxygen saturation monitoring: a prospective cohort study*.
Topics: Arterial Pressure; Cardiotonic Agents; Catheterization, Central Venous; Central Venous Pressure; Child; Child, Preschool; Dobutamine; Dopamine; Female; Fluid Therapy; Heart Rate; Hospital Mortality; Humans; Infant; Male; Monitoring, Physiologic; Oxygen; Prospective Studies; Respiration, Artificial; Shock, Septic; Time Factors; Treatment Outcome; Vena Cava, Superior | 2014 |
Hemodynamic changes in preterm neonates with septic shock: a prospective observational study*.
Topics: Acinetobacter Infections; Candidemia; Cardiotonic Agents; Dobutamine; Dopamine; Echocardiography; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluid Therapy; Heart Rate; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Klebsiella Infections; Male; Prospective Studies; Shock, Septic; Staphylococcal Infections; Stroke Volume | 2014 |
Sepsis, venous return, and teleology.
Topics: Algorithms; Blood Pressure; Cardiac Output; Coronary Circulation; Critical Illness; Dihydroergotamine; Dobutamine; Heart Rate; Hemodynamics; Humans; Milrinone; Models, Cardiovascular; Norepinephrine; Propanolamines; Shock, Septic; Tilt-Table Test; Vascular Resistance | 2014 |
Pediatric shock.
Topics: Dobutamine; Dopamine; Epinephrine; Fluid Therapy; Humans; Infant; Male; Norepinephrine; Phosphodiesterase Inhibitors; Shock, Septic; Vasoconstrictor Agents | 2015 |
Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.
Topics: Data Collection; Dobutamine; Dopamine; Humans; Intensive Care Units; Norepinephrine; Shock; Shock, Cardiogenic; Shock, Septic; Surveys and Questionnaires; Vasoconstrictor Agents; Vasodilator Agents | 2015 |
Septic arthritis and subsequent fatal septic shock caused by Vibrio vulnificus infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Cardiotonic Agents; Cefuroxime; Denmark; Dobutamine; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Meropenem; Microbial Sensitivity Tests; Shock, Septic; Thienamycins; Vibrio Infections; Vibrio vulnificus | 2015 |
Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
Topics: Aged; Comparative Effectiveness Research; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Male; Middle Aged; Norepinephrine; Phenylephrine; Retrospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2017 |
Management of Neonatal Hypotension.
Topics: Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Humans; Hypotension; Infant, Newborn; Long Term Adverse Effects; Milrinone; Shock, Septic | 2017 |
Echoes of the past?
Topics: Cardiac Output, Low; Cardiotonic Agents; Cross-Sectional Studies; Dobutamine; Drug Therapy, Combination; Echocardiography, Transesophageal; Epinephrine; Hemodynamics; Hospital Mortality; Humans; Norepinephrine; Prognosis; Resuscitation; Shock, Septic; Stroke Volume; Survival Rate; Ventricular Dysfunction, Left | 2008 |
Dobutamine and terlipressin in patients with septic shock.
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
A comparison of central and mixed venous oxygen saturation in circulatory failure.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Heart Function Tests; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Norepinephrine; Oxygen; Respiration, Artificial; ROC Curve; Sample Size; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2010 |
Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
Topics: Anti-Infective Agents; Biomarkers; Cardiotonic Agents; Child; Child, Preschool; Creatine Kinase, MB Form; Dobutamine; Electrocardiography; Female; Hospital Mortality; Humans; Infant; Intensive Care Units, Pediatric; Male; Prognosis; Prospective Studies; Sepsis; Shock, Septic; Troponin I | 2008 |
Effects of dobutamine on gut mucosal nitric oxide production during endotoxic shock in rabbits.
Topics: Animals; Coronary Circulation; Dobutamine; Heart Rate; Intestinal Mucosa; Lactic Acid; Lipopolysaccharides; Nitrates; Nitric Oxide; Nitrites; Perfusion; Rabbits; Shock, Septic | 2009 |
Levosimendan vs dobutamine in septic shock.
Topics: APACHE; Cardiotonic Agents; Dobutamine; Humans; Hydrazones; Lactic Acid; Pyridazines; Randomized Controlled Trials as Topic; Shock, Septic; Simendan | 2009 |
Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
Topics: Animals; Blood Pressure; Blood Volume; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Fluid Therapy; Heart Rate; Hemodynamics; Hydrazones; Hypotension; Lactic Acid; Lipopolysaccharides; Liver Circulation; Norepinephrine; Oxygen; Pyridazines; Regional Blood Flow; Shock, Septic; Simendan; Splanchnic Circulation; Swine; Time Factors; Vascular Resistance | 2009 |
Direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in isolated septic rat hearts.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Heart; Heart Rate; Hydrazones; In Vitro Techniques; Male; Models, Animal; Myocardium; Oxygen Consumption; Peritonitis; Pyridazines; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Simendan; Therapeutic Equivalency | 2010 |
The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: intravital video-microscopy analysis.
Topics: Animals; Capillaries; Cardiotonic Agents; Dobutamine; Dopamine; Endotoxemia; Epinephrine; Escherichia coli Infections; Intestine, Small; Lactic Acid; Lipopolysaccharides; Mesenteric Veins; Microcirculation; Microscopy, Video; Norepinephrine; Phenylephrine; Rats; Rats, Inbred WKY; Shock, Septic; Vasoconstrictor Agents | 2010 |
Effects of combination dobutamine and vasopressin therapy on microcirculatory blood flow in a porcine model of severe endotoxic shock.
Topics: Acid-Base Equilibrium; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Heart Rate; Microcirculation; Severity of Illness Index; Shock, Septic; Stroke Volume; Sus scrofa; Vasoconstrictor Agents; Vasopressins | 2011 |
Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels.
Topics: Analysis of Variance; Dobutamine; Epinephrine; Female; Humans; Hydrocortisone; Intensive Care Units; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Norepinephrine; Prospective Studies; Sepsis; Severity of Illness Index; Shock, Septic; Time Factors; Transcortin; Vasoconstrictor Agents | 2010 |
Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity?
Topics: Adult; Aged; Aged, 80 and over; alpha 1-Antitrypsin; Cardiotonic Agents; Dobutamine; Dopamine; Female; Humans; Immunity, Innate; Interleukin-6; Interleukin-8; Leukocyte Elastase; Male; Middle Aged; Neutrophils; Norepinephrine; Shock, Septic; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents; Young Adult | 2012 |
SvO(2)-guided resuscitation for experimental septic shock: effects of fluid infusion and dobutamine on hemodynamics, inflammatory response, and cardiovascular oxidative stress.
Topics: Animals; Dobutamine; Hemodynamics; Norepinephrine; Oxidative Stress; Oxygen Consumption; Resuscitation; Shock, Septic; Swine | 2011 |
Noradrenaline use for septic shock in children: doses, routes of administration and complications.
Topics: Bacteremia; Child; Child, Preschool; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Infant; Male; Norepinephrine; Respiratory Tract Infections; Retrospective Studies; Shock, Septic; Vasoconstrictor Agents | 2012 |
Symmetric peripheral gangrene.
Topics: Adrenergic alpha-Agonists; Amputation, Surgical; Anti-Bacterial Agents; Cardiotonic Agents; Disseminated Intravascular Coagulation; Dobutamine; Dopamine; Fingers; Gangrene; Humans; Male; Middle Aged; Norepinephrine; Pyelonephritis; Shock, Septic; Toes | 2013 |
Optimal adrenergic support in septic shock due to peritonitis.
Topics: Adrenergic Agents; Animals; Body Temperature; Cardiotonic Agents; Dobutamine; Dopamine; Female; Hemodynamics; Lactic Acid; Norepinephrine; Oxygen Consumption; Peritonitis; Regional Blood Flow; Respiratory Mechanics; Sheep; Shock, Septic; Survival Analysis; Sympathomimetics | 2003 |
[Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
Topics: Adrenergic beta-Agonists; Aged; Catecholamines; Dobutamine; Drug Resistance; Female; Hemodynamics; Humans; Infusions, Intravenous; Lypressin; Male; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2003 |
[Comparison of effect of norepinephrine-dobutamine and that of dopamine alone on splanchnic perfusion in sheep with septic shock].
Topics: Animals; Dobutamine; Dopamine; Female; Male; Norepinephrine; Oxygen Consumption; Sheep; Shock, Septic; Splanchnic Circulation | 2003 |
Global end-diastolic volume as an indicator of cardiac preload in patients with septic shock.
Topics: Adult; Aged; Aged, 80 and over; Blood Volume; Cardiac Output; Cardiac Volume; Central Venous Pressure; Dobutamine; Female; Fluid Therapy; Heart; Humans; Hydroxyethyl Starch Derivatives; Male; Middle Aged; Plasma Substitutes; Shock, Septic; Stroke Volume; Thermodilution; Thorax; Vascular Resistance | 2003 |
Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia.
Topics: Animals; Dobutamine; Dopamine; Gastrointestinal Tract; Microcirculation; Shock, Septic; Swine | 2004 |
Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock.
Topics: Adrenergic beta-Agonists; Animals; Blood Gas Analysis; Cardiac Output; Dobutamine; Female; Fluid Therapy; Hemodynamics; Hemostatics; Hypotension; Lactic Acid; Microdialysis; Pyruvic Acid; Regional Blood Flow; Shock, Septic; Splanchnic Circulation; Swine; Vasopressins | 2004 |
Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department.
Topics: Aged; Central Venous Pressure; Clinical Protocols; Dobutamine; Emergency Service, Hospital; Endpoint Determination; Female; Fluid Therapy; Humans; Hypotension; Intensive Care Units; Male; Middle Aged; Monitoring, Physiologic; Oxygen; Resuscitation; Sepsis; Shock, Septic; Vasoconstrictor Agents | 2006 |
Sublingual capnometry tracks microcirculatory changes in septic patients.
Topics: Aged; Belgium; Blood Gas Monitoring, Transcutaneous; Cardiotonic Agents; Dobutamine; Female; Humans; Intensive Care Units; Male; Microcirculation; Middle Aged; Mouth Floor; Regional Blood Flow; Research; Shock, Septic | 2006 |
Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Topics: Adult; Aged; Aorta; Blood Pressure; Cardiac Output; Cardiotonic Agents; Diastole; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Oxygen; Prospective Studies; Shock, Septic; Systole; Vascular Resistance; Ventricular Function, Left | 2006 |
Comment on "Sublingual capnometry tracks microcirculatory changes in septic patients" by Creteur et al.
Topics: Administration, Sublingual; Adrenergic beta-Agonists; Capnography; Dobutamine; Humans; Microcirculation; Shock, Septic | 2006 |
Dobutamine to rescue the microcirculation?
Topics: Adrenergic beta-Agonists; Dobutamine; Hemodynamics; Humans; Microcirculation; Shock, Septic | 2006 |
Vasoactive drug support in septic shock.
Topics: Adult; Blood Pressure; Cardiac Output; Child, Preschool; Dobutamine; Dopamine; Heart Rate; Humans; Norepinephrine; Resuscitation; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2006 |
Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study.
Topics: Acidosis; Analysis of Variance; Animals; Cardiotonic Agents; Dobutamine; Endotoxemia; Hydrazones; Lactic Acid; Oxygen; Prospective Studies; Pyridazines; Random Allocation; Sheep; Shock, Septic; Simendan; Splanchnic Circulation | 2007 |
[Therapeutic options to improve the microcirculation in sepsis and septic shock].
Topics: Blood Flow Velocity; Cardiotonic Agents; Dobutamine; Environmental Monitoring; Humans; Microcirculation; Nitric Oxide Synthase Type II; Protein C; Recombinant Proteins; Sepsis; Shock, Septic; Vasodilation | 2007 |
Catecholamine treatment for shock--equally good or bad?
Topics: Adrenergic Agonists; Dobutamine; Drug Therapy, Combination; Epinephrine; Humans; Norepinephrine; Shock, Septic | 2007 |
Acute hypercapnia improves indices of tissue oxygenation more than dobutamine in septic shock.
Topics: Adrenergic beta-Agonists; Animals; Carbon Dioxide; Cardiac Output; Disease Models, Animal; Dobutamine; Female; Heart Rate; Hypercapnia; Oxygen; Sheep; Shock, Septic | 2008 |
Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants.
Topics: Blood Pressure; Dobutamine; Dopamine; Fluid Therapy; Humans; Infant, Newborn; Lactates; Norepinephrine; Prospective Studies; Shock, Septic; Vasoconstrictor Agents | 2008 |
Is myocardial adrenergic responsiveness depressed in human septic shock?
Topics: Adrenergic beta-Agonists; Adult; Aged; Dobutamine; Echocardiography; Elasticity; Female; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Shock, Septic; Vasodilator Agents; Ventricular Dysfunction, Left | 2008 |
Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Rate; Hemodynamics; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sepsis; Shock, Septic; Survival Analysis; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Vascular Resistance; Ventricular Function, Left | 2008 |
Cardiovascular and metabolic responses to catecholamine and sepsis prognosis: a ubiquitous phenomenon?
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sepsis; Shock, Septic; Survival Analysis; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Vascular Resistance; Ventricular Function, Left | 2008 |
Dopamine and dobutamine in septic shock. A comparison.
Topics: Catecholamines; Dobutamine; Dopamine; Hemodynamics; Humans; Prospective Studies; Shock, Septic; Wounds and Injuries | 1984 |
Effects of 2-[(5-chloro-2-methoxyphenyl)azo]-1H-imidazole (M6434) on hemorrhagic, cardiogenic, and endotoxin shock in rats and rabbits.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Diuresis; Dobutamine; Dopamine; Heart Rate; Imidazoles; Male; Myocardium; Phosphocreatine; Rabbits; Rats; Rats, Inbred Strains; Renal Circulation; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic; Sympathomimetics | 1984 |
[Catecholamines in internal medicine emergencies].
Topics: Acute Disease; Catecholamines; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Oxygen Consumption; Shock, Cardiogenic; Shock, Septic | 1984 |
A comparison of the cardiovascular effects of dobutamine and a new dopamine derivative (D4975) during shock induced by E. coli endotoxin.
Topics: Animals; Blood Pressure; Catecholamines; Cats; Dobutamine; Dopamine; Endotoxins; Escherichia coli; Female; Heart; Heart Rate; Male; Shock, Septic; Theophylline | 1980 |
Acute myocardial failure during Yersinia enterocolitica infection.
Topics: Adult; Coronary Circulation; Dobutamine; Female; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Shock, Septic; Yersinia Infections | 1982 |
Dobutamine: a hemodynamic evaluation in human septic shock.
Topics: Adult; Aged; Catecholamines; Dobutamine; Hemodynamics; Humans; Middle Aged; Shock, Septic | 1981 |
[Myocardial dysfunction in septic shock].
Topics: Adult; Animals; Dobutamine; Dogs; Furosemide; Heart Ventricles; Hemodynamics; Humans; Male; Myocardial Contraction; Shock, Septic | 1981 |
Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green.
Topics: Aged; Coronary Artery Bypass; Dobutamine; Female; Femoral Artery; Humans; Indicator Dilution Techniques; Indocyanine Green; Male; Middle Aged; Pancreatitis; Regional Blood Flow; Respiratory Distress Syndrome; Shock, Septic; Splanchnic Circulation | 1995 |
Pulmonary extraction of dobutamine in critically ill surgical patients.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cardiac Output; Critical Care; Critical Illness; Dobutamine; Female; Humans; Infusions, Intravenous; Lung; Male; Metabolic Clearance Rate; Middle Aged; Pulmonary Artery; Radial Artery; Respiratory Distress Syndrome; Shock, Septic; Surgical Procedures, Operative | 1995 |
Amrinone combined with dobutamine improves hemodynamics and oxygen delivery without down-regulation of cardiac beta-adrenergic receptor density in porcine endotoxemia.
Topics: Amrinone; Animals; Disease Models, Animal; Dobutamine; Down-Regulation; Drug Therapy, Combination; Hemodynamics; Hydrogen-Ion Concentration; Oxygen Consumption; Radioligand Assay; Receptors, Adrenergic, beta; Shock, Septic; Sodium Bicarbonate; Swine; Ventricular Function, Right | 1995 |
Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock.
Topics: Adult; Aged; Angiotensinogen; Dobutamine; Female; Gonadal Steroid Hormones; Humans; Infusions, Intravenous; Male; Middle Aged; Radioimmunoassay; Renin; Shock; Shock, Septic; Systemic Inflammatory Response Syndrome | 1994 |
The relationship between mixed venous and hepatic venous O2 saturation in patients with septic shock.
Topics: Dobutamine; Dopamine; Dopamine Agents; Epinephrine; Hepatic Veins; Humans; Norepinephrine; Oxygen; Oxygen Consumption; Shock, Septic; Splanchnic Circulation; Veins | 1994 |
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
Topics: Animals; Arginine; Cardiovascular System; Dobutamine; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Male; Nitric Oxide; omega-N-Methylarginine; Prospective Studies; Random Allocation; Shock, Septic; Time Factors | 1994 |
Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats.
Topics: Adrenergic Agonists; Animals; Cardiac Output; Dobutamine; Dopamine; Endotoxins; Escherichia coli; Hemodynamics; Lipopolysaccharides; Male; Rats; Rats, Wistar; Regional Blood Flow; Shock, Septic | 1993 |
Absence of supply dependence of oxygen consumption in patients with septic shock.
Topics: Adult; Aged; Aged, 80 and over; Anaerobic Threshold; Blood Gas Analysis; Calorimetry, Indirect; Carbon Dioxide; Cardiac Output; Dobutamine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Oximetry; Oxygen; Oxygen Consumption; Oxygen Inhalation Therapy; Prospective Studies; Pulmonary Gas Exchange; Severity of Illness Index; Shock, Septic; Survival Rate; Thermodilution | 1993 |
Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines.
Topics: Adult; Aged; Bacterial Infections; Catecholamines; Critical Illness; Cyclic AMP; Dobutamine; Heart; Heart Rate; Hemodynamics; Humans; Middle Aged; Prospective Studies; Receptors, Adrenergic, beta; Shock, Septic | 1993 |
Effects of norepinephrine and dobutamine on oxygen transport and consumption in a dog model of endotoxic shock.
Topics: Animals; Blood Pressure; Cardiac Output; Dobutamine; Dogs; Norepinephrine; Oxygen; Oxygen Consumption; Prospective Studies; Random Allocation; Shock, Septic; Vascular Resistance | 1993 |
[Hepatic venous and mixed venous O2 saturation during catecholamine therapy in patients with septic shock].
Topics: Dobutamine; Dopamine; Epinephrine; Humans; Norepinephrine; Oxygen; Shock, Septic | 1993 |
[Improving tissue perfusion without invasive monitoring. Apropos of a case].
Topics: Carbon Dioxide; Cardiac Output; Cardiotonic Agents; Dobutamine; Echocardiography, Transesophageal; Epinephrine; Humans; Monitoring, Physiologic; Oxygen Consumption; Shock, Septic | 1995 |
Regional effects of dobutamine in endotoxic shock.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Dobutamine; Dogs; Dose-Response Relationship, Drug; Gastric Mucosa; Hemodynamics; Manometry; Pressure; Regional Blood Flow; Renal Circulation; Shock, Septic; Splanchnic Circulation | 1996 |
Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock.
Topics: Adrenergic beta-Agonists; Dobutamine; Glucose; Humans; Liver; Oxygen Consumption; Shock, Septic; Splanchnic Circulation | 1997 |
Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Escherichia coli Infections; Glomerular Filtration Rate; Heart Rate; Kidney; Male; Rats; Rats, Wistar; Sepsis; Shock, Septic; Sodium; Urine; Vasodilator Agents | 1997 |
Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Evaluation, Preclinical; Female; Hemodynamics; Hydrogen-Ion Concentration; Infusions, Intravenous; Intestinal Mucosa; Laser-Doppler Flowmetry; Random Allocation; Shock, Septic; Swine | 1997 |
Recommendations for the treatment of patients with septic shock.
Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Blood Pressure; Cardiac Output; Cardiotonic Agents; Clinical Protocols; Dobutamine; Dopamine; Epinephrine; Fluid Therapy; Humans; Norepinephrine; Oxygen Consumption; Shock, Septic; Splanchnic Circulation; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Vasoactive drugs and splanchnic perfusion in septic shock.
Topics: Blood Flow Velocity; Dobutamine; Epinephrine; Humans; Norepinephrine; Oxygen Consumption; Shock, Septic; Splanchnic Circulation; Sympathomimetics; Vasoconstrictor Agents | 1998 |
Effects of dobutamine, norepinephrine and epinephrine on intramucosal pH and hemodynamics of dogs during endotoxic shock.
Topics: Animals; Dobutamine; Dogs; Epinephrine; Gastric Acidity Determination; Hemodynamics; Lactic Acid; Norepinephrine; Resuscitation; Shock, Septic | 1998 |
Intestinal blood flow and intramucosal pH in experimental peritonitis.
Topics: Animals; Blood Flow Velocity; Carbon Dioxide; Cardiotonic Agents; Colloids; Dobutamine; Female; Guinea Pigs; Hydrogen-Ion Concentration; Intestinal Mucosa; Ischemia; Male; Oxygen; Peritonitis; Shock, Septic; Splanchnic Circulation | 1999 |
A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients.
Topics: Carbon Dioxide; Cardiac Output; Catheterization, Peripheral; Dobutamine; Female; Gastric Mucosa; Humans; Infusions, Intravenous; Linear Models; Liver Circulation; Male; Middle Aged; Oxygen Consumption; ROC Curve; Sensitivity and Specificity; Sepsis; Shock, Septic; Splanchnic Circulation; Statistics, Nonparametric; Sympathomimetics | 1999 |
Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Catecholamines; Cytokines; Dobutamine; Dopamine; Epinephrine; Gene Expression Regulation; Granulocytes; Humans; Immune Tolerance; Interleukin-1; Interleukin-10; Interleukin-6; Lipopolysaccharides; Metoprolol; Middle Aged; Monocytes; Norepinephrine; RNA, Messenger; Shock, Septic; Tumor Necrosis Factor-alpha | 1999 |
[Dobutamine and amrinone in septic shock patients].
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Humans; Shock, Septic | 1999 |
Effects of dobutamine on hepato-splanchnic hemodynamics in an experimental model of hyperdynamic endotoxic shock.
Topics: Adrenergic beta-Agonists; Animals; Blood Gas Analysis; Dobutamine; Dogs; Hemodynamics; Lactic Acid; Liver; Liver Circulation; Oxygen; Resuscitation; Shock, Septic; Splanchnic Circulation | 2001 |
[Suprahepatic vein catheterization in 4 cases of severe septic shock].
Topics: Adult; Aged; Catheterization, Peripheral; Critical Care; Dobutamine; Fatal Outcome; Female; Follow-Up Studies; Hemodynamics; Hepatic Veins; Humans; Male; Middle Aged; Multiple Organ Failure; Oxygen Consumption; Shock, Septic; Splanchnic Circulation; Vasodilator Agents | 2001 |
Silent transmural myocardial ischemia during septic shock in a patient with normal coronary arteries.
Topics: Aged; Cardiotonic Agents; Coronary Vessels; Dobutamine; Electrocardiography; Humans; Male; Myocardial Ischemia; Shock, Septic | 2001 |
Anti-inflammatory effects of inotropic drugs in the treatment of septic shock: another piece to the puzzle.
Topics: Cardiotonic Agents; Cytokines; Dobutamine; Humans; Liver; Shock, Septic | 2001 |
Prognostic value of dobutamine stress test in patients with septic shock.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen Consumption; Prognosis; Shock, Septic | 2001 |
Comparison of norepinephrine-dobutamine to dopamine alone for splanchnic perfusion in sheep with septic shock.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Dobutamine; Dopamine; Drug Synergism; Hemodynamics; Norepinephrine; Random Allocation; Sheep; Shock, Septic; Splanchnic Circulation | 2002 |
[Sympathomimetic amines].
Topics: Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epinephrine; Kidney; Shock, Cardiogenic; Shock, Septic; Sympathomimetics; Vasoconstrictor Agents | 1979 |
Comparative haemodynamic effects of dopamine and dobutamine in septic shock.
Topics: Catecholamines; Dobutamine; Dopamine; Hemodynamics; Humans; Shock, Septic | 1979 |
Addition of alinidine, a specific bradycardic agent, to dobutamine in a canine model of endotoxic shock.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Clonidine; Disease Models, Animal; Dobutamine; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Escherichia coli Infections; Hemodynamics; Prospective Studies; Random Allocation; Shock, Septic; Time Factors | 1992 |
Total body blood volume redistribution in porcine E. coli septic shock: effect of volume loading, dobutamine, and norepinephrine.
Topics: Animals; Blood Volume; Dobutamine; Escherichia coli Infections; Fluid Therapy; Hemodynamics; Liver; Norepinephrine; Shock, Septic; Swine | 1991 |
Adjuvant effects of beta-adrenergic drugs on indomethacin treatment of newborn canine endotoxic shock.
Topics: Adjuvants, Pharmaceutic; Animals; Animals, Newborn; Dobutamine; Dogs; Dopamine; Drug Therapy, Combination; Escherichia coli; Hemodynamics; Indomethacin; Lipopolysaccharides; Shock, Septic | 1991 |
The accuracy of the Biox 3700 pulse oximeter in patients receiving vasoactive therapy.
Topics: Blood Pressure; Dobutamine; Dopamine; Female; Heart Rate; Humans; Male; Middle Aged; Oximetry; Oxygen; Prospective Studies; Respiration, Artificial; Shock, Septic | 1991 |
The assessment of the microcirculatory effects of dobutamine using mercury in silastic strain gauge plethysmography in man.
Topics: Dobutamine; Hemorrhage; Humans; Microcirculation; Plethysmography; Shock, Septic; Venous Pressure | 1991 |
Goal directed therapy with dobutamine in a porcine model of septic shock: effects on systemic and renal oxygen transport.
Topics: Animals; Dobutamine; Hemodynamics; Kidney; Oxygen; Peritonitis; Renal Circulation; Shock, Septic; Swine | 1991 |
Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation.
Topics: Acute Disease; Coronary Artery Bypass; Dobutamine; Dopamine; Humans; Liver Circulation; Norepinephrine; Oxygen; Oxygen Consumption; Respiratory Insufficiency; Shock, Septic; Vasoconstrictor Agents | 1991 |
[Hemodynamic effects of dobutamine in hyperkinetic septic shock treated with norepinephrine].
Topics: Adult; Aged; Blood Gas Analysis; Dobutamine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Lactates; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Plasma Substitutes; Prospective Studies; Shock, Septic | 1991 |
Adrenergic support during anesthesia in experimental endotoxin shock: norepinephrine versus dobutamine.
Topics: Analysis of Variance; Anesthesia, General; Animals; Blood Gas Analysis; Dobutamine; Dogs; Drug Interactions; Enflurane; Hemodynamics; Ketamine; Lactates; Norepinephrine; Shock, Septic | 1991 |
Renal effects of norepinephrine used to treat septic shock patients.
Topics: Adult; Aged; Creatinine; Diuresis; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Kidney; Male; Middle Aged; Norepinephrine; Shock, Septic | 1990 |
Dobutamine administration in septic shock: addition to a standard protocol.
Topics: Adult; Aged; Aged, 80 and over; Dobutamine; Drug Evaluation; Female; Hemodynamics; Humans; Infusions, Intravenous; Lactates; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Respiration, Artificial; Shock, Septic | 1990 |
Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine.
Topics: Adult; Aged; Combined Modality Therapy; Dobutamine; Female; Fluid Therapy; Humans; Male; Middle Aged; Norepinephrine; Shock, Septic | 1990 |
[Use of norepinephrine in the treatment of septic shock].
Topics: Adult; Aged; Aged, 80 and over; Clinical Protocols; Dobutamine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Shock, Septic | 1989 |
Use of survivors' cardiorespiratory values as therapeutic goals in septic shock.
Topics: Adult; Aged; Critical Care; Dobutamine; Dopamine; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Plasma Substitutes; Prospective Studies; Shock, Septic | 1989 |
Adjuvant effects of beta-adrenergic drugs in the indomethacin treatment of highly lethal endotoxic shock.
Topics: Animals; Dobutamine; Dopamine; Drug Synergism; Drug Therapy, Combination; Indomethacin; Isoproterenol; Male; Rats; Rats, Inbred Strains; Shock, Septic | 1988 |
Volume expansion, dobutamine and noradrenaline for treatment of right ventricular dysfunction in porcine septic shock: a combined invasive and radionuclide study.
Topics: Animals; Dobutamine; Endotoxins; Escherichia coli; Heart Ventricles; Hemodynamics; Norepinephrine; Radionuclide Imaging; Shock, Septic; Stroke Volume; Swine | 1987 |
Reversal of intractable septic shock with norepinephrine therapy.
Topics: Adult; Aged; Critical Care; Dobutamine; Dopamine; Female; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Plasma Substitutes; Shock, Septic | 1988 |
Dobutamine for myocardial depression in meningococcemia.
Topics: Cardiac Output, Low; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Humans; Meningococcal Infections; Middle Aged; Sepsis; Shock, Septic | 1988 |
Dobutamine in elderly septic shock patients refractory to dopamine.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Resistance; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Shock, Septic; Vascular Resistance | 1987 |
Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration.
Topics: Animals; Dobutamine; Dogs; Dopamine; Drug Evaluation, Preclinical; Fluid Therapy; Hemodynamics; Resuscitation; Shock, Septic; Time Factors | 1987 |
[Coronary circulation and myocardial metabolism in septic shock. Effects of a dobutamine-dopamine combination].
Topics: Blood Pressure; Coronary Circulation; Dobutamine; Dopamine; Drug Therapy, Combination; Humans; Myocardium; Oxygen Consumption; Shock, Septic | 1987 |
Cardiorespiratory failure in toxic shock syndrome: effect of dobutamine.
Topics: Adolescent; Adult; Blood Pressure; Body Surface Area; Cardiac Output; Catecholamines; Dobutamine; Echocardiography; Electrocardiography; Female; Hemodynamics; Humans; Male; Myocardial Contraction; Pulmonary Wedge Pressure; Respiratory Insufficiency; Shock, Septic; Vascular Resistance | 1985 |
[Acute myocardial dysfunction in meningococcal septicemia].
Topics: Acute Disease; Adult; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Dobutamine; Dopamine; Female; Hemodynamics; Humans; Male; Meningococcal Infections; Shock, Septic | 1985 |